Kaisa Health Group Holdings Limited (HK:0876)
:0876
Want to see HK:0876 full AI Analyst Report?
Top Page
Kaisa Health Group Holdings Limited
(0876)
Select Model
Select Model
Rating:41Neutral
Price Target:
HK$0.05
▼(-45.56% Downside)
Action:Reiterated
Date:06/05/26
The score is driven primarily by weak financial performance (declining revenue, widening losses, and persistently negative cash flow), partially offset by low leverage. Technicals remain bearish with price below key moving averages and negative MACD, despite oversold readings. Valuation provides little support because the company is loss-making and no dividend yield is available.
Positive Factors
Low leverage / conservative balance sheet
Persistently low debt-to-equity reduces solvency risk and gives the company financing flexibility while it works to stabilise operations. Over a 2–6 month horizon this conservatism increases runway, lowers refinancing pressure, and supports the ability to access capital or restructure without immediate distress.
Negative Factors
Sustained negative cash generation
Consistent operating and free cash flow deficits are a structural concern: ongoing cash burn forces reliance on external financing or asset draws, constrains reinvestment, and raises solvency risk if losses continue. Over months, this limits strategic flexibility and increases pressure on liquidity management.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / conservative balance sheet
Persistently low debt-to-equity reduces solvency risk and gives the company financing flexibility while it works to stabilise operations. Over a 2–6 month horizon this conservatism increases runway, lowers refinancing pressure, and supports the ability to access capital or restructure without immediate distress.
Read all positive factors
Kaisa Health Group Holdings Limited (0876) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$257.15M
Dividend YieldN/A
Average Volume (3M)76.64M
Price to Earnings (P/E)―
Beta (1Y)1.35
Revenue Growth-24.95%
EPS Growth-1.09%
CountryHK
Employees861
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.46
Shares Outstanding5,042,139,000
10 Day Avg. Volume53,429,215
30 Day Avg. Volume76,644,739
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.88
Price to Sales (P/S)2.54
P/FCF Ratio-6.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kaisa Health Group Holdings Limited Business Overview & Revenue Model
Company Description
Kaisa Health Group Holdings Limited operates as an investment holding company, primarily focused on the manufacturing and global distribution of dental prosthetics across the People's Republic of China and international markets. Its comprehensive ...
How the Company Makes Money
null...
Kaisa Health Group Holdings Limited Financial Statement Overview
Summary
Income Statement
27
Negative
Balance Sheet
68
Positive
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 139.11M | 185.36M | 185.88M | 191.50M | 209.63M |
| Gross Profit | 50.64M | 81.86M | 81.07M | 82.56M | 97.42M |
| EBITDA | -48.31M | -12.70M | 27.56M | -132.02M | 45.58M |
| Net Income | -46.68M | -46.35M | 7.47M | -123.32M | 2.36M |
Balance Sheet | |||||
| Total Assets | 471.71M | 517.59M | 605.07M | 767.60M | 971.33M |
| Cash, Cash Equivalents and Short-Term Investments | 109.60M | 149.61M | 174.08M | 173.45M | 259.26M |
| Total Debt | 13.46M | 10.65M | 18.00M | 31.87M | 32.28M |
| Total Liabilities | 73.21M | 91.10M | 113.30M | 296.69M | 288.49M |
| Stockholders Equity | 403.38M | 431.15M | 492.01M | 485.33M | 651.12M |
Cash Flow | |||||
| Free Cash Flow | -58.41M | -37.31M | -45.51M | -81.53M | -137.09M |
| Operating Cash Flow | -47.32M | -32.32M | -34.64M | -67.53M | -122.00M |
| Investing Cash Flow | 6.52M | 23.42M | 44.50M | 2.02M | 141.67M |
| Financing Cash Flow | -6.22M | -7.82M | -7.34M | -7.08M | 70.09M |
Kaisa Health Group Holdings Limited Technical Analysis
Negative
0.09
Price Trends
0.09
Negative
0.13
Negative
0.10
Negative
Market Momentum
-0.01
Positive
21.85
Positive
11.97
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0876, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.09, and below the 200-day MA of 0.10, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 21.85 is Positive, neither overbought nor oversold. The STOCH value of 11.97 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0876.
Kaisa Health Group Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$5.41B | 9.07 | 16.76% | 3.65% | 11.07% | 48.01% | |
69 Neutral | HK$6.76B | 22.02 | 11.30% | ― | 25.24% | 7.29% | |
67 Neutral | HK$1.66B | 16.15 | 3.68% | 7.46% | 7.11% | -34.66% | |
66 Neutral | HK$11.71B | 72.04 | 4.01% | ― | ― | ― | |
62 Neutral | HK$14.70B | 8.09 | 6.64% | 4.58% | 2.34% | -22.25% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
41 Neutral | HK$257.15M | -0.11 | ― | ― | -24.95% | -1.09% |
* Healthcare Sector Average
HK:0876
Kaisa Health Group Holdings Limited
0.05
0.03
168.42%
HK:1066
Shandong Weigao Group Medical Polymer Co
3.25
-2.58
-44.23%
HK:1358
PW Medtech Group Ltd.
1.15
0.04
3.79%
HK:3600
Modern Dental Group Limited
5.79
1.87
47.82%
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
32.00
7.74
31.92%
HK:6699
Angelalign Technology Inc.
68.50
16.49
31.70%
Kaisa Health Group Holdings Limited Corporate Events
Kaisa Health Sets 2026 AGM to Approve Accounts and Share Issuance Mandate
Jun 4, 2026
Kaisa Health Group Holdings has convened its annual general meeting for 29 June 2026 in Hong Kong, where shareholders will receive the audited consolidated financial statements for the year ended 31 December 2025 alongside the directors’ and...
Kaisa Health Clarifies Share Consolidation, Odd-Lot and Certificate Arrangements
Jun 3, 2026
Kaisa Health Group Holdings has detailed arrangements surrounding its planned share consolidation and related change in board lot size, including provisions to help shareholders manage odd lots of consolidated shares. The company has appointed Gra...
Kaisa Health Calls Special Meeting for Acquisition Approval and Major Share Consolidation
Jun 1, 2026
Kaisa Health Group Holdings Limited has convened a special general meeting in Hong Kong on 22 June 2026, seeking shareholder approval for the acquisition of Embrace Blossom Limited and the issuance of consideration shares to Profit Vigorous Develo...
Kaisa Health Revises Timetable for Share Consolidation and Board Lot Change
Jun 1, 2026
Kaisa Health Group Holdings Limited has revised the timetable for a proposed share consolidation and change in board lot size, after delaying the dispatch of a circular to shareholders. The plan will consolidate every 50 existing shares into one n...
Kaisa Health Delays Circular and Timetable for Major Acquisition and Share Consolidation
May 14, 2026
Kaisa Health Group Holdings has postponed the dispatch of a shareholder circular related to a very substantial acquisition, a connected transaction involving the issue of consideration shares under a specific mandate, and a proposed share consolid...
Kaisa Health Narrows Overall Loss Despite Revenue Drop in 2025
Mar 25, 2026
Kaisa Health Group Holdings Limited reported a sharp revenue decline to HK$139.1 million for 2025 from HK$185.4 million a year earlier, as rising selling and distribution expenses and increased research and development costs pressured margins. Des...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.